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The Center for Global Health and Prevention (CDC) has been collaborating 
with Ministry of Health in the Kyrgyz Republic since 1995 to better recognize and 
respond to serious public health threats. In 1995, CDC formally established an office 
in Almaty, Kazakhstan, to serve as the home base for coordinating activities in five 
countries of Central Asia. CDC aims to strengthen the capacity to detect, prevent, 
and control disease and respond to public health threats in the Kyrgyz Republic. In 
2011, CDC opened its country office in Bishkek, Kyrgyzstan. 
Global HIV/AIDS 
Through its Central Asia Regional Global HIV/AIDS office in Almaty, Kazakhstan and 
country office in Bishkek, CDC provides support to the Ministry of Health (MOH) 
and other partners in Kyrgyzstan. This support includes direct technical assistance 
to the MOH and other indigenous partners in strengthening their HIV prevention, 
and care and treatment programs and health systems capacity. CDC strengthens 
public health systems in Kyrgyzstan by focusing on strategic information, blood 
safety, injection safety, laboratory services, and prevention for at-risk and 
vulnerable populations for HIV/AIDS treatment and care services. 
Specific prevention activities are designed to implement evidence-based pilot 
programs to illustrate and test prevention programs, identify and adopt cost 
effective modes of service delivery, and expand prevention and related services for 
high-risk populations. Similarly, focus areas for HIV care and treatment services are 
to build the capacity of clinicians through training and on-the-job mentoring, 
strengthen HIV and opportunistic infection treatment and care services, develop 
clinical guidelines for screening and managing HIV infection, and enhance 
screening for and diagnosis of HIV infection and co-infection. 
Strengthening Laboratory Capacity 
CDC efforts to strengthen partner country laboratory diagnostic capacity and 
capability to safely and rapidly assess public health emergencies is an office-wide 
approach that focuses on strengthening the safety of the blood supply, diagnosing 
hepatitis and influenza, and examining antimicrobial susceptibility. 
Global Disease Detection (GDD) 
The GDD Regional Center in the Central Asia Region (CAR), based in Almaty, 
Kazakhstan, is one of ten established around the world to help countries identify 
and respond to emerging diseases. The GDD Regional Center in Kazakhstan 
collaborates with key in-country partners in the Kyrgyz Republic making it truly a 
regional platform in scope. These regional centers work with WHO and MOH to 
strengthen core infrastructure requirements (e.g., laboratory detection, clinical 
surveillance, outbreak investigation and control) needed to comply with the 
International Health Regulations (IHR). 
 
Staff 
CDC office (physical 
presence) 
No U.S. Assignees 
3 Locally Employed 
 
At a Glance  
Population: 5,667,800 
Per capita income: $2,200 
Life expectancy at birth 
women/men: 73/65 yrs 
Under 5 mortality: 25/1000 
live births 
Source: Population Reference Bureau Fact 
Sheet, 2011 
 
Top 10 Causes of Death 
1. Ischemic Heart Disease 
25% 
2. Stroke 15% 
3. Cancer 8% 
4. Lower Respiratory 
Infections 6% 
5. Chronic Obstructive 
Pulmonary Disease 5% 
6. Cirrhosis 5% 
7. Road Injuries 3% 
8. Pre-Term Birth 
Complications 3% 
9. Neonatal Encephalitis 2% 
10. Self-Harm 2% 














GDD Kyrgyzstan includes the four core component 
programs described below. The following programs are 
implemented in Kyrgyzstan by GDD: 
International Emerging Infections Program (IEIP) 
CDC IEIP staff work with key stakeholders to improve 
detection, control, and prevention of emerging infectious 
diseases. Strategies include strengthening epidemiology, 
surveillance, laboratory capability, training, and evidence-
based public health research and practice. IEIP’s activities 
have led to improved understanding of the causes and 
burden of varying diseases such as hepatitis, influenza 
and Crimean-Congo hemorrhagic fever in the Kyrgyz 
Republic and other Central Asia countries, and the data 
have been used to inform public health policy decisions, 
evaluate new tools for improving disease diagnosis and 
treatment, and strengthen epidemiologic and laboratory 
capacity. 
Field Epidemiology and Laboratory Training 
Program (FELTP) 
The CDC Division of Public Health Systems and Workforce 
Development (DPHSWD) has been working in Central 
Asia since 2003 to build workforce capacity and 
strengthen public health systems. DPHSWD supports the 
participating countries’ Ministries of Health (MoH) in training public health officers through a two -year 
Regional Field Epidemiology and Laboratory Training Program (FELTP), located in Almaty, Kazakhstan, that 
focuses on applied epidemiology, disease surveillance, outbreak response, and program evaluation. While 
enrolled, residents continue working in their respective country's health system and are well-positioned to 
serve as first responders to outbreaks, as well as leaders and mentors for future in -country specialists in field 
epidemiology. 
Global Influenza 
Knowledge of the epidemiology of influenza in Central Asia and preparation for a possible pandemic has 
increased substantially because of CDC’s collaborative work in the Kyrgyz Republic since 2008. Two sentinel 
surveillance sites for influenza-like illness (ILI) and severe acute respiratory illness (SARI) were established in 





Impact in Kyrgyzstan 
 14 epidemiologists from Kyrgyz Republic have been 
trained in modern methods of epidemiology as part 
of CDC/CAR’s Field Epidemiology and Laboratory 
Training Program (FELTP) and have developed 
capacity to improve the health of the country’s 
citizens.  
 CDC facilitated nation-wide implementation of an 
electronic HIV case-management system (EHCMS) in 
Kazakhstan and has begun nation-wide 
implementation of EHCMS in Kyrgyzstan and 
Tajikistan.  
 CDC conducted assessments of HIV Integrated Bio-
Behavioral Surveillance (IBBS) in Kazakhstan, 
Kyrgyzstan, and Uzbekistan. To address deficiencies 
identified by the assessments, CDC supported 
national technical working groups to draft and 
implement new standard operating procedures for 
IBBS. 
 
For more information please contact Centers for Disease Control and Prevention: 
CDC-Atlanta  
1600 Clifton Road NE, Atlanta, GA 30333  
Email: cgh@cdc.gov  
Web: http://www.cdc.gov/global     
 
  
    
 
For more country information:  http://www.cdc.gov/globalhealth/countries/kyrgyzstan 
